Daily Bulletin

Enrolment of First Two Patients in PRISTINE Study with SELUTION SLR™ Sirolimus Drug Eluting Balloon-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Enrolment of First Two Patients in PRISTINE Study with SELUTION SLR™ Sirolimus Drug Eluting Balloon-PR Newswire APAC

NYON, Switzerland, Oct. 12, 2020 /PRNewswire/ -- MedAlliance has announced enrolment of the first two patients in the PRISTINE registry with SELUTION SLR™ 018 DEB for the treatment of patients with Below The Knee disease (Chronic Limb Threatening Ischemia). This is the first DEB accepted by the FDA for its "Breakthrough Program". SELUTION...

Read more: Enrolment of First Two Patients in PRISTINE Study with SELUTION SLR™ Sirolimus Drug Eluting...

Business News

What is a Union and Why It Matters for Workers' Rights

When asking, "What is a union?" the answer lies in understanding their crucial role in shaping the rights and conditions that workers enjoy today. From universal superannuation to the concept of the...

Daily Bulletin - avatar Daily Bulletin

How Does Climate Impact Shed Durability and Design Choices?

Climate plays a crucial role in determining the durability and design choices for sheds. The weather conditions in a specific area can significantly impact the longevity and performance of these str...

Daily Bulletin - avatar Daily Bulletin

Your Essential Guide to International Shipping: Fast, Safe, and Cost-Effective

International shipping is the backbone of global trade, connecting companies and consumers across borders. Whether you're an online retailer shipping orders internationally or sending gifts to frien...

Daily Bulletin - avatar Daily Bulletin